Navigation Links
Series 590 Low Cost Whole Blood Aggregometers

ProductsSeries 590 Low Cost Whole Blood Aggregometers
Company Chrono-log Corporation
Item Series 590 Low Cost Whole Blood Aggregometers
Features Easy to use, they are ideal for drug studies and for platelet function testing in small and large laboratories. These low cost Aggregometers measure platelet aggregation directly in whole blood, eliminating the time and expense of preparing plasma. An accurate platelet aggregation result can be obtained within seven minutes of venipuncture. The WBA is ideal for testing the effects of anti-platelet drugs on platelet function, since platelets are tested in their natural environment. Ease of operation, with automatic setting of baseline and gain and the elimination of sample manipulation, makes it feasible for platelet aggregation to be tested inexpensively in laboratories of any size. User training time is also reduced, resulting in additional cost savings.
Description Chrono-log's wide range of Platelet aggregometers allows to choose the instrument capabilities to meet particular needs. Single, dual and four sample units are available, with chart recorder outputs or digital computer outputs. In addition to the Chrono-log Optical aggregometers, which measure platelet aggregation in platelet-rich-plasma (PRP), Chrono-log supplies: Whole blood aggregometers which measure aggregation directly in whole blood. Lumi-aggregometers which simultaneously measure aggregation and ATP secretion. Intracellular Ionized Calcium aggregometers, which measure intracellular ionized calcium flux simultaneously with aggregation. Small, low cost WBA whole blood aggregometers provide a front panel digital display of the aggregation amplitude as well as automatic setting of baseline and gain. The WBA is valuable when you must have a rapid, reliable and cost-effective screen to detect specific platelet abnormalities.
Info Chrono-log Corporation
Customer Service: (800) 247-6665
Web site: http://www.chronolog.com/

Related medicine products :

1. Series 20000 Legacy
2. Series 24 Watt Sealed CO2 OEM Lasers
3. M/MK Series
4. EA/EKA Series
5. EHS Series
6. MLS-Series Top-Loading Autoclaves
7. Blood Coagulation Analyzer CG Series
8. Cytomics FC 500 Series
9. Series 400 Aggregometers
10. Series 500 Aggregometers
11. Series 490 Low Cost Automatic Optical Aggregometers
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:7/23/2014)... AB (PRWEB) July 23, 2014 ... of in-home care for seniors, is proud to announce ... Series featuring experts in a wide range of health ... clinical social worker and award-winning author Nancy Kriseman, and ... and ways to prevent burnout by becoming more self-aware. ...
(Date:7/23/2014)... News) -- Regularly checking the pulse of a stroke ... "Screening pulse is the method of choice for checking ... have never had a stroke. Our study shows it ... to identify people who might need more thorough monitoring ... Bernd Kallmunzer, of Erlangen University in Germany. ...
(Date:7/23/2014)... The National Institute of Biomedical Imaging and Bioengineering ... Symposium on July 30, 2014 on the NIH campus. ... investigators covering a wide breadth of NIBIB-funded research. ... Cohen, Harvard, Engineering Microbial Rhodopsins as Optical Voltage Sensor, ... Fluorescently Labeled Probes for Nerve Imaging ...
(Date:7/23/2014)... Angeles, CA (PRWEB) July 23, 2014 ... practices delivering Enhanced External Counterpulsation (EECP), is ... who receives EECP therapy at the health center. ... ischemic heart disease. Since receiving ongoing EECP therapy since ... , When Sara Soulati, CEO of Global Cardio Care, ...
(Date:7/23/2014)... Fragile X syndrome ( FXS ) is a genetic ... behaviors on the autistic spectrum, as well as cognitive ... mental impairment and the most common cause of autism. ... Riverside have published a study that sheds ... Appearing online today (July 23) in the Journal ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3
... ATLANTA , March 17 Stonebranch, the industry ... businesses and Job Scheduling technology , announced today ... Safe Harbor: What the HITECH Act Means for U.S. Healthcare ... recent healthcare regulations and how healthcare organizations (HCOs), related covered ...
... rate is higher with metal staples, review finds , ... common when orthopedic surgeons use metal staples instead of ... , Infections after surgery can lead to longer hospital ... hip replacement. Infected wounds can also cause serious complications. ...
... March 17 Anatomist and Inventor of Plastination, Dr. ... present their new exhibition, BODY WORLDS of ... premiering at the Neunkirchen Zoo in Germany , beginning ... menagerie, the display features the most revered species in the animal ...
... ... extend to visualize all network communications in the enterprise and those extending out to ... ... of a major update to its Versiera Infrastructure Management System, including new groundbreaking technology ...
... ... Health Makeover Contest and announces that they are increasing the amount of smile makeover winners ... ... nation’s foremost voice in unbiased, expert advice on how to care for your smile and ...
... ... Strategic Leadership Development program for its current and potential physician leaders, through New York ... ... participating in a Strategic Leadership Development program for its current and potential physician leaders. ...
Cached Medicine News:Health News:Stonebranch Publishes Healthcare IT White Paper 2Health News:Stonebranch Publishes Healthcare IT White Paper 3Health News:Stonebranch Publishes Healthcare IT White Paper 4Health News:Gunther von Hagens' BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo 2Health News:Gunther von Hagens' BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo 3Health News:Versiera Enables Cloud and Enterprise Network Visualization 2Health News:Versiera Enables Cloud and Enterprise Network Visualization 3Health News:Dear Doctor Magazine Reveals Makeover Contest Winner's Results and Expands Contest to Include Additional Winners 2Health News:Dear Doctor Magazine Reveals Makeover Contest Winner's Results and Expands Contest to Include Additional Winners 3Health News:Summit Medical Group Prepares Physicians for Future Leadership 2
(Date:7/23/2014)... 2014 Announced at the 20 th ... agreement seeks to increase access to a promising new HIV ... 2014 conference in Melbourne today, the ... Gilead Sciences for tenofovir alafenamide (TAF), a promising new medicine ... in India and China ...
(Date:7/23/2014)... 2014 Today,s U.S. Food and Drug ... with relapsed chronic lymphocytic leukemia (CLL), follicular lymphoma ... significant advance for patients with these blood cancers.  ... trade name Zydelig®, is a first-in-class inhibitor of ... in many B-cell malignancies and plays a critical ...
(Date:7/23/2014)... ALTO, Calif., July 23, 2014  Varian Medical Systems ... earnings of $1.02 per diluted share in the third ... impacted by about $0.06 per diluted share due to ... portion of Varian,s existing equity investment in Augmenix, a ... company-wide revenues totaled $748 million for the third quarter ...
Breaking Medicine Technology:The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 2The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 3The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10